Chronic Exposure to Nitric Oxide Induces P53 Mutations and Malignant-like Features in Human Breast Epithelial Cells

被引:3
|
作者
Cheng, Robert Y. S. [1 ]
Burkett, Sandra [2 ]
Ambs, Stefan [3 ]
Moody, Terry [4 ]
Wink, David A. A. [1 ]
Ridnour, Lisa A. A. [1 ]
机构
[1] NCI, Canc Innovat Lab, Ctr Canc Res, Frederick, MD 21702 USA
[2] NCI, Mol Cytogenet Sect, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA
[3] NCI, Lab Human Carcinogenesis, Ctr Canc Res, Bethesda, MD 20892 USA
[4] NCI, Ctr Canc Training, Off Training & Educ, Bethesda, MD 20892 USA
关键词
nitric oxide; TP53; mutation; breast cancer; PREDICTS POOR SURVIVAL; TUMOR-SUPPRESSOR GENE; CANCER STEM-CELLS; K-RAS; TP53; MUTATION; DNA-DAMAGE; INFLAMMATION; NOS2; MICROENVIRONMENT; ACTIVATION;
D O I
10.3390/biom13020311
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The small endogenous signaling molecule nitric oxide (NO) has been linked with chronic inflammation and cancer. The effects of NO are both concentration and temporally dependent; under some conditions, NO protects against damage caused by reactive oxygen species and activates P53 signaling. During chronic inflammation, NO causes DNA damage and inhibits repair proteins. To extend our understanding of the roles of NO during carcinogenesis, we investigated the possible effects of chronic NO exposure on MCF10A breast epithelial cells, as defined by changes in cellular morphology, chromosome/genomic stability, RNA, and protein expression, and altered cell phenotypes. Human MCF10A cells were maintained in varying doses of the NO donor DETANO for three weeks. Distinct patterns of genomic modifications in TP53 and KRAS target genes were detected in NO-treated cells when compared to background mutations. In addition, quantitative real-time PCR demonstrated an increase in the expression of cancer stem cell (CSC) marker CD44 after prolonged exposure to 300 mu M DETANO. While similar changes in cell morphology were found in cells exposed to 300-500 mu M DETANO, cells cultured in 100 mu M DETANO exhibited enhanced motility. In addition, 100 mu M NO-treated cells proliferated in serum-free media and selected clonal populations and pooled cells formed colonies in soft agar that were clustered and disorganized. These findings show that chronic exposure to NO generates altered breast epithelial cell phenotypes with malignant characteristics.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Chronic exposure to nitric oxide drives human breast epithelial cells to malignant-like features
    Cheng, Yuk Sing Robert
    Anderson, Stephen K.
    McVicar, Daniel W.
    Wink, Daivd A.
    Ridnour, Lisa A.
    CANCER RESEARCH, 2017, 77
  • [2] There's NO Business Like p53 Business Nitric Oxide Regulates Phosphorylation of p53 in Chronic Inflammatory Disease
    Kim, Peter K. M.
    Billiar, Timothy R.
    CELL CYCLE, 2003, 2 (02) : 111 - 112
  • [3] P53 MUTATIONS IN HUMAN EPITHELIAL SKIN TUMORS
    MOLES, JP
    MAZARS, R
    GUILLOT, B
    GUILHOU, JJ
    THEILLET, C
    BASSETSEGUIN, N
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (04) : 514 - 514
  • [4] Nitric oxide induces phosphorylation of p53 and impairs nuclear export
    Nicole Schneiderhan
    Andreja Budde
    Yanping Zhang
    Bernhard Brüne
    Oncogene, 2003, 22 : 2857 - 2868
  • [5] Nitric oxide induces phosphorylation of p53 and impairs nuclear export
    Schneiderhan, N
    Budde, A
    Zhang, YP
    Brüne, B
    ONCOGENE, 2003, 22 (19) : 2857 - 2868
  • [6] NITRIC-OXIDE INDUCES P53 AND APOPTOSIS IN VASCULAR SMOOTH-MUSCLE CELLS
    ZHAO, Z
    RAVID, K
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 2547 - 2547
  • [7] Nitric oxide induces oral squamous cell carcinoma cells apoptosis with p53 accumulation
    Zhao, SF
    Tong, XY
    Zhu, FD
    ORAL ONCOLOGY, 2005, 41 (08) : 785 - 790
  • [8] p53 mutations in tumors derived from irradiated human thyroid epithelial cells
    Gamble, SC
    Cook, MC
    Riches, AC
    Herceg, Z
    Bryant, PE
    Arrand, JE
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1999, 425 (02) : 231 - 238
  • [9] Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma
    Segers, K
    Backhovens, H
    Kumar-Singh, S
    DeVoecht, J
    Ramael, M
    Van Broeckhoven, C
    VanMarck, E
    VIRCHOWS ARCHIV, 1995, 427 (04) : 431 - 436
  • [10] Depletion of TP53 in Human Pluripotent Stem Cells Triggers Malignant-Like Behavior
    Montilla-Rojo, Joaquin
    Eleveld, Thomas F.
    van Soest, Marnix
    Hillenius, Sanne
    Timmerman, Dennis M.
    Gillis, Ad J. M.
    Roelen, Bernard A. J.
    Mummery, Christine L.
    Looijenga, Leendert H. J.
    Salvatori, Daniela C. F.
    ADVANCED BIOLOGY, 2025,